Last update 29 Nov 2024

NKG2C/DAP12-expressing iNK cells+NKG2C/IL-15/CD33 TriKE(University of Minnesota)

Overview

Basic Info

Drug Type
Stem cell therapy
Synonyms
NKG2C/DAP12-expressing iNK cells+NKG2C1533 TriKE
Target
CD33 x IL-15Rα x NKG2C
Mechanism
CD33 modulators(Myeloid cell surface antigen CD33 modulators), IL-15Rα agonists(Interleukin-15 receptor subunit alpha agonists), NKG2C modulators(killer cell lectin like receptor C2 modulators)
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Originator Organization
University of MinnesotaUniversity of Minnesota
Active Organization
Fate Therapeutics, Inc.Fate Therapeutics, Inc.University of California San DiegoUniversity of California San DiegoUniversity of MinnesotaUniversity of Minnesota
+ [1]
Inactive Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with NKG2C/DAP12-expressing iNK cells+NKG2C/IL-15/CD33 TriKE(University of Minnesota)
Login to view more data
100 Translational Medicine associated with NKG2C/DAP12-expressing iNK cells+NKG2C/IL-15/CD33 TriKE(University of Minnesota)
Login to view more data
100 Patents (Medical) associated with NKG2C/DAP12-expressing iNK cells+NKG2C/IL-15/CD33 TriKE(University of Minnesota)
Login to view more data
100 Deals associated with NKG2C/DAP12-expressing iNK cells+NKG2C/IL-15/CD33 TriKE(University of Minnesota)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaDiscovery
US
University of California San DiegoUniversity of California San Diego
-
Acute Myeloid LeukemiaDiscovery
US
Fate Therapeutics, Inc.Fate Therapeutics, Inc.
-
Acute Myeloid LeukemiaDiscovery
US
GT Biopharma, Inc.GT Biopharma, Inc.
-
Acute Myeloid LeukemiaDiscovery
US
University of MinnesotaUniversity of Minnesota
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free